A phase 2/3 trial of BioNTech's immunotherapy for head and neck cancer, BNT113, has failed to meet its objective, but the ...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Robbie Tyrie, founder and managing director of Torridon ...
From patient engagement apps to clinical trial management platforms, development teams are increasingly turning to AI coding ...
Roche has added to its weight-loss drug pipeline again, turning to China's Rona Therapeutics for an RNAi candidate targeting ...
Aspen Neuroscience, which is developing stem cell therapies for Parkinson's disease, has filed an IPO to raise additional ...
Women and girls with autoimmune diseases are much more likely to have their condition misdiagnosed as psychiatric or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results